Login / Signup

PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.

Adam A KrayaKara N MaxwellMonika A EivaBradley S WubbenhorstJohn PlutaMichael FeldmanAnupma NayakDaniel J PowellSusan M DomchekRobert A AndersKatherine L Nathanson
Published in: JCO precision oncology (2022)
-associated ovarian cancers may inform considerations around how to optimally deploy immune checkpoint inhibitors in the clinic.
Keyphrases
  • dna methylation
  • breast cancer risk
  • primary care
  • cell proliferation
  • gene expression
  • transcription factor
  • pi k akt
  • signaling pathway